Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5
NCT00000356 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2017-01-12
Summary
The purpose of this study is to determine the pharmacokinetics of L-alpha-acetylmethadol (LAAM) in adults transferred from methadone maintenance treatment for opiate dependence.
Conditions
- Opioid-Related Disorders
- Substance-Related Disorders
Interventions
- DRUG
-
LAAM
Sponsors & Collaborators
- collaborator OTHER
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Charles O'Brien, M.D., Ph.D. · PDVAMC Treatment Research Center
Study Design
- Purpose
- TREATMENT
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1991-06-30
- Primary Completion
- 1992-08-31
- Completion
- 1992-10-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of [14c]-Samidorphan (Also Known as ALKS 33) in Healthy, Male Volunteers
NCT02504463 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3
NCT00000354 ·Status: COMPLETED ·Phase: PHASE1
-
Nalmefene Implant in Healthy Subjects
NCT07325279 ·Status: RECRUITING ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of REL-1017 (d-Methadone)
NCT03637361 ·Status: COMPLETED ·Phase: PHASE1
-
PO Methadone Ortho Outpatient
NCT06351215 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Opioid Rotation From Morphine to Methadone in Treatment of Non-malignant Pain
NCT00356083 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
NCT00000358 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075
NCT03248947 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Open-Label, Safety Study of Lofexidine
NCT02363998 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacodynamic Evaluation of Intranasal Nalmefene
NCT04828005 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
NCT00000355 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
NCT00000328 ·Status: WITHDRAWN ·Phase: PHASE2
-
Pharmacokinetics and Pharmacodynamics of Buprenorphine in Healthy Volunteers
NCT00347815 ·Status: UNKNOWN ·Phase: PHASE1
-
Effects of Dronabinol in Opioid Maintained Patients
NCT04025359 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Multicenter Clinical Trial of Buprenorphine - 3
NCT00000207 ·Status: COMPLETED ·Phase: PHASE3
-
Methadone/Buprenorphine Cross-Over Study - 4
NCT00000208 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients
NCT01559454 ·Status: COMPLETED ·Phase: PHASE4
-
Ketamine for Opioid Use Disorder
NCT06943859 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluating the Safety of Acute Baclofen in Methadone-maintained Individuals With Opiate Dependence.
NCT05161351 ·Status: COMPLETED ·Phase: PHASE4
-
Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients
NCT01650649 ·Status: COMPLETED ·Phase: PHASE1
-
Hyperalgesia in Methadone Patients: Can it be Treated?
NCT00333242 ·Status: UNKNOWN ·Phase: PHASE1
-
Acetazolamide in Central Sleep Apnea Patients Using Medication for Opioid Use Disorder
NCT06521476 ·Status: RECRUITING ·Phase: PHASE2
-
Study of D-Methadone in Patients With Chronic Pain
NCT00588640 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
NAOMI: A Study to Compare Medically-prescribed Heroin With Oral Methadone in Chronic Opiate Addiction
NCT00175357 ·Status: COMPLETED ·Phase: PHASE3
-
Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
NCT04464980 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2